|
|
|
| |
|
|
| |
The latest ovarian cancer news from News Medical |
|
|
|
 | | | Generative AI may help scientists connect the many layers of cancer A Cell Perspective argues that generative AI models could help tackle cancer’s multiscale, multimodal complexity by complementing the Hallmarks of Cancer framework. It proposes that models capable of complex pattern recognition, multimodal fusion, and contextual reasoning could improve cancer detection, biological discovery, and precision oncology, while still requiring rigorous validation and human oversight. | | | | | Chronic wildfire smoke exposure may raise long-term cancer risks Exposure to wildfire smoke was associated with a significantly increased risk of lung, colorectal, breast, bladder, and blood cancer, according to results from a study presented at the American Association for Cancer Research (AACR) Annual Meeting 2026, held April 17-22. | |
|
|
|  | | | | | Why do the deadliest cancers still get less NIH research funding? Researchers found that NIH funding for major US cancers does not consistently align with lethality, with highly fatal cancers such as pancreatic cancer and small-cell lung cancer receiving far less funding per estimated death than breast or prostate cancer. The study argues that incidence alone is not enough and that funding decisions should better incorporate mortality, survival, and mortality-to-incidence ratios. | |  | | | | | How chemotherapy causes taste changes and loss of appetite Chemotherapy can make food taste metallic, bland, or unpleasant, turning everyday eating into a clinical challenge that affects appetite, nutrition, and recovery. | |  | | | | | Cryopreservation that preserves viability and function across cancer research workflows See how Bambanker™ supports high post-thaw recovery and reliable downstream performance across tissues, organoids, tumor digests, and more. | |
|
|
|  | | | An innovative type of CAR T cell therapy, called KIR-CAR, was shown to be safe, with increasing efficacy corresponding to higher doses of the investigational treatment in nine patients with advanced ovarian cancer, mesothelioma or cholangiocarcinoma (bile duct cancer), according to an early report from an ongoing Phase I dose-escalation clinical trial. | | | | | A drug that helps the immune system find cancer cells also helps patients avoid having their bladders surgically removed (cystectomy), a new study shows. | |
|
|
|
|
|
|
|